MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 4, 1998, Pages 299-308

  Felix, Carolyn A ^a   Hosler, Matthew R ^a   Slater, Diana J ^a   Parker, Robert I ^e   Masterson, Margaret ^f   Whitlock, James A ^g   Rebbeck, Timothy R ^b   Nowell, Peter C ^c,d   Lange, Beverly J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Cancer Center   (United States)

^c Laboratory Medicine   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e STONY BROOK UNIVERSITY   (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g VANDERBILT UNIVERSITY   (United States)

Author keywords

Breakpoint; MLL; Rearrangement; Translocation

Indexed keywords

DNA; MEMBRANE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; FEMALE; GENE; GENE TRANSLOCATION; HUMAN; IMMUNOPHENOTYPING; INFANT; KARYOTYPE; MALE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE FACTORS; BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; DISEASES IN TWINS; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; INFANT, NEWBORN; KARYOTYPING; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TREATMENT OUTCOME;

EID: 0031761672     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199807000-00004     Document Type: Article

References (54)

1. Cimino G, Lo Coco F, Biondi A, et al. ALL-1 gene at chromosome 11q23 is consistently altered in acute leukemia of early infancy. Blood 1993;82:544-6.
2. Pui C-H, Kane JR, Crist WM. Biology and treatment of infant , leukemias. Leukemia 1995;9:762-9.
3. Hilden JM, Frestedt JL, Moore RO, et al. Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4:11)(q21;q23). Blood 1995;86:3876-82.
4. Chen C-S, Sorensen PHB, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993;81:2386-93.
5. Martinez-Climent JA, Thirman MJ, Espinosa R, et al. Detection of 11q23/MLL rearrangements in infant leukemias with fluorescence in situ hybridization and molecular analysis. Leukemia 1995; 9;1299-304.
6. Raimondi SC. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 1993;81:2237-51.
7. Felix CA, Hosler MR, Winick NJ, et al. ALL-1 gene rearrangements in DNA topoisomerase 11 inhibitor-related leukemia in children. Blood 1995;85:3250-6.
8. Thirman MJ, Gill HJ, Burnett RC, et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993;329:909-14.
9. Super HJG, McCabe NR, Thirman MJ, et al. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA topoisomerase II. Blood 1993;82:3705-11.
10. Kobayashi H, Espinosa R, Thirman MJ, et al. Do terminal deletions of 11q23 exist? Identification of undetected translocations with fluorescence in situ hybridization. Genes Chromosomes Cancer 1993;7:204-8.
11. Prasad R, Gu Y, Alder H, et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 1993;53:5624-8.
12. Yamamoto K, Seto M, Iida S, et al. A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 1994;83:2912-21.
13. Sorenson PHB, Smith FO, Chen C-S, et al. Molecular rearrangements of chromosme band 11q23 are common in infant AML and are strongly correlated with monocytic or myelomonocytic phenotype. Blood 1992;80:255a.
14. Schichman SA, Caligiuri MA, Gu Y, et al. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994;91:6236-9.
15. Schichman SA, Caligiuri MA, Strout MP, et al. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 1994;54:4277-80.
16. Megonigal MD, Rappaport EF, Jones DH, et al. Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proc Natl Acad Sci USA 1997;94:11583-8.
17. Gu Y, Cimino G, Alder H, et al. The (4;11)(q21;q23) chromosome translocations in acute leukemias involve the VDJ recombinase. Proc Natl Acad Sci USA 1992;89:10464-8.
18. Negrini M, Felix CA, Martin C, et al. Potential topoisomerase II DNA binding sites at the breakpoints of a t(9;11) chromosome translocation in acute myeloid leukemia. Cancer Res 1993;53:4489-92.
19. Domer PH, Fakharzadeh SS, Chen C-S, et al. Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product. Proc Natl Acad Sci USA 1993;90:7884-8.
20. Corral J, Forster A, Thompson S, et al. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci USA 1993;90:8538-42.
21. Gu Y, Alder H, Nakamura T, et al. Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res 1994;54:2327-30.
22. Chen AY, Liu LF. DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 1994;84:191-218.
23. Pommier Y. DNA topoisomerase I and II in cancer chemotherapy: update and perspectives. Cancer Chemother Pharmacol 1993;32:103-8.
24. Froelich-Ammon SJ, Osheroff N. Topoisomerase poisons: Harnessing the dark side of enzyme mechanisms. J Biol Chem 1995;270:21429-32.
25. Capranico G, Zunino F. DNA topoisomerase II-trapping antitumor drugs. Eur J Cancer 1992;28A:2055-60.
26. Broeker PLS, Super HG, Thirman MJ, et al. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and therapy-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 1996;87:1912-22.
27. Bennett JM, Catovsky D, Daniel MT, et al. The morphological classification of acute lymphoblastic leukemia: concordance among observers and clinical correlations. Br J Haematol 1981;47:553-61.
28. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia, a report of the French-American-British cooperative group. Ann Intern Med 1985;103:620-9.
29. Felix CA, Poplack DG, Reaman GH, et al. Characterization of immunoglobulin and T-cell receptor gene patterns in B-cell precursor acute lymphoblastic leukemia of childhood. J Clin Oncol 1990;8:431-42.
30. Felix CA, Wasserman R, Lange BJ, et al. Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations. Leukemia 1994;8:963-7.
31. Felix CA, Wasserman R, Cesano A, et al. Clonal expansion of germline B-lineage acute lymphoblastic leukemia in severe combined immunodeficient mice. Oncogene 1995;11:1753-9.
32. Felix C, Kim C, Megonigal M, et al. Panhandle PCR amplifies genomic translocation breakpoint involving unknown partner gene. Blood 1997;90:4679-86.
33. Bayar E, Kurczynski TW, Robinson MG, et al. Monozygotic twins with congenital acute lymphoblastic leukemia (ALL) and t(4;11)(q21;q23). Cancer Genet Cytogenet 1996;89:177-80.
34. Gu Y, Nakamura T, Alder H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila Trithorax, to the AF-4 gene. Cell 1992;71:701-8.
35. Beverloo HB, Coniat ML, Wijsman J, et al. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res 1995;55:4220-4.
36. Bernard O, Mauchauffe M, Mecucci C, et al. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogene 1994;9:1039-45.
37. Nakamura T, Alder H, Gu Y, et al. Genes on chromosomes 4,9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs. Proc Natl Acad Sci USA 1993;90:4631-5.
38. Rubnitz JE, Morrissey J, Savage PA, et al. ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994;84:1747-52.
39. Thirman MJ, Levitan DA, Kobayashi H, et al. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994;91:12110-4.
40. Tse W, Zhu W, Chen HS, et al. A novel gene, AF1q, fused to MLL in t(1;11)(q21;q23), is specifically expressed in leukemic and immature hematpoietic cells. Blood 1995;85:650-6.
41. Chaplin T, Bernard O, Beverloo HB, et al. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 1995;86:2073-6.
42. Chaplin T, Ayton P, Bernard OA, et al. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukemia. Blood 1995;85:1435-41.
43. Parry P, Wei Y, Evans G. Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family. Genes Chromosomes Cancer 1994;11:79-84.
44. Rubnitz JE, Link MP, Shuster JJ, et al. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1994;84:570-3.
45. Biondi A, Rambaldi A, Rossi V, et al. Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation. Blood 1993;82:2943-7.
46. Downing JR, Head DR, Raimondi SC, et al. The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia. Blood 1994;83:330-5.
47. Rubnitz JE, Behm FG, Curcio-Brint AM, et al. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. Blood 1996;87:4804-8.
48. Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Kruppel-like zinc finger gene and retinoic acid receptor - a locus due to a variant t(11;17) translocation associated with acute promyelocytic leukemia. EMBO J 1993;12:1161-7.
49. Akao Y, Seto M, Takahashi T, et al. The RCK gene associated with t(11;14) translocation is distinct from the MLL/ALL-1 gene with t(4;11) and t(11;19) translocations. Cancer Res 1992;52:6083-7.
50. Jones C, Slijepcevic P, Marsh S, et al. Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet 1995;3:2123-30.
51. Cimino G, Rapanotti MC, Biondi A, et al. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res 1997;57:2879-83.
52. Ross JA, Potter JD, Reaman GH, et al. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control 1996;7:581-90.
53. Felix CA, Lange BJ, Hosler MR, et al. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 1995;55:4287-92.
54. Aplan PD, Chervinsky DS, Stanulla M, et al. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 1996;87:2649-58.